Icon

ROCKLATAN (nda208259)- (0.005%;EQ 0.02% BASE)

LATANOPROST; NETARSUDIL DIMESYLATE ALCON LABS INC
0.005%;EQ 0.02% BASE
Yes Yes
2034-Mar-14 2022-Dec-18
None None
None No
ROCKLATAN® 0.02%/0.005% is a fixed dose combination of a Rho kinase inhibitor and a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
0 1 0
Total Other Developers 11
Drugs with Suitability No
0.005%;EQ 0.02% BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.